Molecular Tumor Board–Assisted Care in an Advanced Cancer Population: Results of a Phase II Clinical Trial

Overview of attention for article published in JCO Precision Oncology, September 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

news: 2 news outlets

twitter: 12 X users

Readers on

mendeley: 15 Mendeley

So far, Altmetric has seen 16 X posts from 12 X users, with an upper bound of 25,242 followers.

Molecular Tumor Board–Assisted Care in an Advanced Cancer Population: Results of a Phase II Clinical Trial https://t.co/WyFFBCpGlr

RT @JCOPO_ASCO: .@MeganLeigh127 @UKMarkey et al describe a phase 2 trial where 59% of patients treated based on molecular tumor board recom…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 12 additional X posts.